Background: The HIV-1 accessory protein Nef is an important determinant of lentiviral pathogenicity that contributes to disease progression by enhancing viral replication and other poorly understood mechanisms. Nef mediates diverse functions including downmodulation of cell surface CD4 and MHC Class I, enhancement of viral infectivity, and enhancement of T cell activation. Nef interacts with a multiprotein signaling complex that includes Src family kinases, Vav1, CDC42, and activated PAK2 (p21-activated kinase 2). Although previous studies have attempted to identify a biological role for the Nef-PAK2 signaling complex, the importance of this complex and its constituent proteins in Nef function remains unclear.

Results: Here, we show that Nef mutants defective for PAK2-association, but functional for CD4 and MHC Class I downmodulation and infectivity enhancement, are also defective for the ability to enhance viral replication in primary T cells that are infected and subsequently activated by sub-maximal stimuli (1 μg/ml PHA-P). In contrast, these Nef mutants had little or no effect on HIV-1 replication in T cells activated by stronger stimuli (2 μg/ml PHA-P or anti-CD3/CD28-coated beads). Viruses bearing wild-type Nefs, but not Nef mutants defective for PAK2 association, enhanced NFAT and IL2 receptor promoter activity in Jurkat cells. Moreover, expression of wild-type Nefs, but not mutant Nefs defective for PAK2 association, was sufficient to enhance responsiveness of primary CD4 and CD8 T cells to activating stimuli in Nef-expressing and bystander cells. siRNA knockdown of PAK2 in Jurkat cells reduced NFAT activation induced by anti-CD3/CD28 stimulation both in the presence and absence of Nef, and expression of a PAK2 dominant mutant inhibited Nef-mediated enhancement of CD25 expression.

Conclusion: Nef-mediated enhancement of cellular activation and viral replication in primary T cells is dependent on PAK2 and on the strength of the activating stimuli, and correlates with the ability of Nef to associate with PAK2. PAK2 is likely to play a role in Nef-mediated enhancement of viral replication and immune activation in vivo.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169461PMC
http://dx.doi.org/10.1186/1742-4690-8-64DOI Listing

Publication Analysis

Top Keywords

nef-mediated enhancement
16
viral replication
16
replication primary
12
primary cells
12
nef mutants
12
nef
9
enhancement cellular
8
cellular activation
8
cells
8
cells dependent
8

Similar Publications

Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.

AIDS

November 2024

National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.

Article Synopsis
  • The study examines how long-term evolution of the HIV-1 Nef protein affects its ability to counteract the host factor SERINC5, which plays a role in viral infectivity.
  • Analysis involved comparing Nef isolates from different infection stages in 19 individuals with subtype B or C HIV-1, revealing that subtype B showed a decline in Nef's ability to inhibit SERINC5 over time, unlike subtype C.
  • The findings suggest that specific mutations in Nef are linked to variations in its function against SERINC5 and highlight the limited influence of host T cell responses on these mutations, providing insights into HIV-1 pathogenesis.*
View Article and Find Full Text PDF

The HIV-1 Nef accessory factor enhances the viral life cycle in vivo, promotes immune escape of HIV-infected cells, and represents an attractive antiretroviral drug target. However, Nef lacks enzymatic activity and an active site, complicating traditional occupancy-based drug development. Here we describe the development of proteolysis targeting chimeras (PROTACs) for the targeted degradation of Nef.

View Article and Find Full Text PDF

Nef is an accessory protein unique to the primate HIV-1, HIV-2, and SIV lentiviruses. During infection, Nef functions by interacting with multiple host proteins within infected cells to evade the immune response and enhance virion infectivity. Notably, Nef can counter immune regulators such as CD4 and MHC-I, as well as the SERINC5 restriction factor in infected cells.

View Article and Find Full Text PDF

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity.

Retrovirology

March 2023

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, 4001, South Africa.

Background: Nef performs multiple cellular activities that enhance HIV-1 pathogenesis. The role of Nef-mediated down-regulation of the host restriction factor SERINC5 in HIV-1 pathogenesis is not well-defined. We aimed to investigate if SERINC5 down-regulation activity contributes to HIV-1 subtype C disease progression, to assess the relative contribution of this activity to overall Nef function, and to identify amino acids required for optimal activity.

View Article and Find Full Text PDF
Article Synopsis
  • HIV-1 Nef protein utilizes the clathrin adaptor complex AP-2 to downregulate the viral receptor CD4 and antiviral proteins SERINC3 and SERINC5, which otherwise inhibit virus infectivity.
  • In Jurkat cells lacking SERINC3 and SERINC5, Nef isn't needed for effective viral replication, but in MOLT-3 cells, Nef remains essential for HIV-1 replication even without these proteins.
  • The study suggests that MOLT-3 cells may contain a novel antiviral factor, as Nef's effect on replication doesn’t rely on known cell signaling partners LCK and PAK2, and is strictly linked to its ability to interact with AP-2.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!